Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Schoergenhofer

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
JACC. Cardiovascular Interventions|August 5, 2019
Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug AbsorptionChristian Schoergenhofer, Bernd Jilma
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisChristian Schoergenhofer, Bernd Jilma
Wiener Klinische Wochenschrift|October 20, 2025
Economic, cultural and social inequalities in potentially inappropriate medication-An Austrian perspectiveChristian Schoergenhofer, Thorsten Bischof, Markus Zeitlinger
Seminars in Thrombosis and Hemostasis|February 8, 2024
Progress in von Willebrand Disease Treatment: Evolution towards Newer TherapiesMiriam M Moser, Christian Schoergenhofer, Bernd Jilma
Annals of Translational Medicine|June 14, 2016
Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort studyChristian Schoergenhofer, Michael Schwameis, Heimo Lagler, et al.
Thrombosis and Haemostasis|July 28, 2020
Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia AGeorg Gelbenegger, Christian Schoergenhofer, Paul Knoebl, et al.
Drug Safety - Case Reports|November 5, 2017
Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with EmpagliflozinGeorg Gelbenegger, Nina Buchtele, Christian Schoergenhofer, et al.
Bioresearch Open Access|June 5, 2018
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 CellsSebastian Dorn, Christian Schoergenhofer, Michael Krainer, et al.
Annals of Internal Medicine|May 19, 2020
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)Christian Schoergenhofer, Bernd Jilma, Thomas Stimpfl, et al.
Human Vaccines & Immunotherapeutics|November 12, 2015
Chikungunya vaccines in developmentMichael Schwameis, Nina Buchtele, Patricia Pia Wadowski, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
JACC. Cardiovascular Interventions|August 5, 2019
Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug AbsorptionChristian Schoergenhofer, Bernd Jilma
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisChristian Schoergenhofer, Bernd Jilma
Wiener Klinische Wochenschrift|October 20, 2025
Economic, cultural and social inequalities in potentially inappropriate medication-An Austrian perspectiveChristian Schoergenhofer, Thorsten Bischof, Markus Zeitlinger
Seminars in Thrombosis and Hemostasis|February 8, 2024
Progress in von Willebrand Disease Treatment: Evolution towards Newer TherapiesMiriam M Moser, Christian Schoergenhofer, Bernd Jilma
Annals of Translational Medicine|June 14, 2016
Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort studyChristian Schoergenhofer, Michael Schwameis, Heimo Lagler, et al.
Thrombosis and Haemostasis|July 28, 2020
Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia AGeorg Gelbenegger, Christian Schoergenhofer, Paul Knoebl, et al.
Drug Safety - Case Reports|November 5, 2017
Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with EmpagliflozinGeorg Gelbenegger, Nina Buchtele, Christian Schoergenhofer, et al.
Bioresearch Open Access|June 5, 2018
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 CellsSebastian Dorn, Christian Schoergenhofer, Michael Krainer, et al.
Annals of Internal Medicine|May 19, 2020
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)Christian Schoergenhofer, Bernd Jilma, Thomas Stimpfl, et al.
Human Vaccines & Immunotherapeutics|November 12, 2015
Chikungunya vaccines in developmentMichael Schwameis, Nina Buchtele, Patricia Pia Wadowski, et al.
Pageof 11